Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sean Brynjelsen currently holds 1,061,194 shares of Sagent Pharmaceuticals, Inc. (SGNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sean Brynjelsen has been a net buyer of SGNT stock. They have purchased $264.1K and sold $0 worth of shares.
Sean Brynjelsen's most recent insider trade was on Jul 14, 2026, when they sold 200,000 shares at $0.00 per share.
Sean Brynjelsen serves as Executive at Sagent Pharmaceuticals, Inc. (SGNT). They have executed 16 insider transactions totaling $264.1K over their tenure at the company.
Sean Brynjelsen holds the position of Executive at Sagent Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Sean Brynjelsen has shown a buying trading pattern, with $264.1K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Sean Brynjelsen was on Jul 14, 2026, when they sold $274.0K worth of ETON shares. This transaction involved 200,000 shares at $1.37 per share.
Sean Brynjelsen currently owns 1,061,194 shares of Sagent Pharmaceuticals, Inc. (SGNT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sean Brynjelsen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sean Brynjelsen has 16 Form 4 filings on record as an insider at Sagent Pharmaceuticals, Inc..
Set alerts for Sean Brynjelsen and 40,000+ other insiders.